{"total":46,"page":1,"pageSize":25,"pages":2,"millis":0,"query":{"q":"","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","kind":"","level":"","type":"","quarter":"","grade":"","collection":"","from":"2020-04-04","to":"","sort":"relevance"},"items":[{"id":"AGY-FED-HEALTH-OTHER-076","kind":"order","level":"federal","jurisdiction":"United States (federal); Federal Bureau of Prisons","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Federal Bureau of Prisons","instrument":"Update on COVID-19 and Home Confinement (Apr. 5, 2020)","title":"Update on COVID-19 and Home Confinement: BOP continuing to aggressively screen potential inmates","dateIssued":"2020-04-05","startDate":"2020-04-05","endDate":"2020-06-30","quarters":["2020Q2"],"types":["OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-076","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-076"},{"id":"AGY-FED-HEALTH-OTHER-016","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-025 (DEA078), Dear Registrant letter permitting opioid treatment programs to use the same off-site location repeatedly to deliver take-home methadone doses without separate registration","title":"Off-site OTP delivery method (Final)","dateIssued":"2020-04-07","startDate":"2020-04-07","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-016","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-016"},{"id":"AGY-FED-HEALTH-OTHER-003","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office for Civil Rights","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Roger T. Severino, Director, Office for Civil Rights, HHS","instrument":"Enforcement Discretion Regarding COVID-19 Community-Based Testing Sites (CBTS) During the COVID-19 Nationwide Public Health Emergency, 85 Fed. Reg. 29637 (May 18, 2020)","title":"Enforcement Discretion Regarding COVID-19 Community-Based Testing Sites (CBTS) During the COVID-19 Nationwide Public Health Emergency","dateIssued":"2020-04-09","startDate":"2020-04-09","endDate":"2023-05-11","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-003","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-003"},{"id":"AGY-FED-HEALTH-OTHER-053","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Denise M. Hinton, Chief Scientist, FDA","instrument":"Emergency Use Authorization: Face Shields (umbrella) (issued Apr. 9, 2020; amended Apr. 13, 2020)","title":"Letter of Authorization, Face Shields (Apr. 13, 2020)","dateIssued":"2020-04-13","startDate":"2020-04-09","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-053","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-053"},{"id":"AGY-FED-HEALTH-OTHER-017","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"William T. McDermott, Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-027 (DEA083), letter to DEA-registered distributors and manufacturers granting an exception to the signed-delivery requirement for narcotic shipments to narcotic treatment programs","title":"DEA Dist/MNF narcotics shipments to OTP signed delivery exception (final)","dateIssued":"2020-04-10","startDate":"2020-04-10","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-017","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-017"},{"id":"AGY-FED-HEALTH-OTHER-018","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"William T. McDermott, Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-028 (DEA084), letter permitting DEA-registered hospitals and clinics to handle controlled substances at satellite locations under the existing registration during the COVID-19 emergency","title":"Hospital/Clinic Registration Exception (final)","dateIssued":"2020-04-10","startDate":"2020-04-10","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-018","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-018"},{"id":"AGY-FED-HEALTH-OTHER-118","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services (Health Resources and Services Administration administering the Provider Relief Fund)","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Secretary of Health and Human Services (terms administered by HRSA)","instrument":"Provider Relief Fund, Acceptance of Terms and Conditions, Relief Fund Payment from Initial $30 Billion General Distribution","title":"Acceptance of Terms and Conditions - Relief Fund Payment from Initial $30 Billion General Distribution","dateIssued":"2020-04-10","startDate":"2020-04-10","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-118","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-118"},{"id":"AGY-FED-HEALTH-OTHER-019","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"William T. McDermott, Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-029 (DEA085), letter granting a temporary exception to the five percent rule for practitioners distributing controlled substances to other registrants during the COVID-19 emergency","title":"DEA 5 percent practitioner exception (final)","dateIssued":"2020-04-13","startDate":"2020-04-13","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-019","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-019"},{"id":"AGY-FED-HEALTH-OTHER-020","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-030 (DEA087), letter extending the off-site take-home delivery flexibility to buprenorphine dispensed by opioid treatment programs","title":"Off site OTP delivery buprenorphine","dateIssued":"2020-04-21","startDate":"2020-04-21","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-020","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-020"},{"id":"AGY-FED-HEALTH-OTHER-025","kind":"context","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Substance Abuse and Mental Health Services Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"SAMHSA, Center for Substance Abuse Treatment, Division of Pharmacologic Therapies","instrument":"FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency","title":"FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency","dateIssued":"2020-04-21","startDate":"2020-04-21","endDate":"2021-11-18","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-025","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-025"},{"id":"AGY-FED-HEALTH-OTHER-033","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, HHS","instrument":"Notice, Guidance Documents Related to Coronavirus Disease 2019 (COVID-19); Availability, 85 Fed. Reg. 27987 (May 12, 2020)","title":"Guidance Documents Related to Coronavirus Disease 2019 (COVID-19); Availability","dateIssued":"2020-05-12","startDate":"2020-05-12","endDate":"2021-12-31","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-033","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-033"},{"id":"AGY-FED-HEALTH-OTHER-077","kind":"order","level":"federal","jurisdiction":"United States (federal); Federal Bureau of Prisons","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Director, Federal Bureau of Prisons","instrument":"COVID-19 Action Plan: Phase Seven (ordered May 18, 2020): all Phase Six measures extended through June 30, 2020","title":"COVID-19 Action Plan: Phase Seven - Agency-wide measures extended","dateIssued":"2020-05-20","startDate":"2020-05-18","endDate":"2020-06-30","quarters":["2020Q2"],"types":["GATH","QUAR","CLOSE","TRAV"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-077","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-077"},{"id":"AGY-FED-HEALTH-OTHER-054","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Denise M. Hinton, Chief Scientist, FDA","instrument":"Emergency Use Authorization: Gowns and Other Apparel (umbrella) (May 22, 2020)","title":"Letter of Authorization, Gowns and Other Apparel","dateIssued":"2020-05-22","startDate":"2020-05-22","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-054","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-054"},{"id":"AGY-FED-HEALTH-OTHER-063","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Veterans Affairs","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Department of Veterans Affairs","instrument":"Interim Final Rule, Informed Consent and Advance Directives, 85 Fed. Reg. 31698 (May 27, 2020)","title":"Informed Consent and Advance Directives","dateIssued":"2020-05-27","startDate":"2020-05-27","endDate":"2022-02-04","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-063","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-063"},{"id":"AGY-FED-HEALTH-OTHER-035","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, HHS","instrument":"Notice, Process for Publishing Emergency Use Authorizations for Medical Devices During Coronavirus Disease 2019, 85 Fed. Reg. 33686 (June 2, 2020)","title":"Process for Publishing Emergency Use Authorizations for Medical Devices During Coronavirus Disease 2019","dateIssued":"2020-06-02","startDate":"2020-06-02","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-035","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-035"},{"id":"AGY-FED-HEALTH-OTHER-034","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, HHS","instrument":"Notice, Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability, 85 Fed. Reg. 34638 (June 5, 2020)","title":"Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability","dateIssued":"2020-06-05","startDate":"2020-06-05","endDate":"2021-06-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-034","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-034"},{"id":"AGY-FED-HEALTH-OTHER-062","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Veterans Affairs","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Department of Veterans Affairs","instrument":"Interim Final Rule, Home Visits in Program of Comprehensive Assistance for Family Caregivers During COVID-19 National Emergency, 85 Fed. Reg. 34523 (June 5, 2020)","title":"Home Visits in Program of Comprehensive Assistance for Family Caregivers During COVID-19 National Emergency","dateIssued":"2020-06-05","startDate":"2020-06-05","endDate":"","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-062","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-062"},{"id":"AGY-FED-HEALTH-OTHER-071","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Justice, Federal Bureau of Prisons","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Bureau of Prisons, Department of Justice (Michael Carvajal, Director)","instrument":"Final Rule, Video Visiting and Telephone Calls Under the Coronavirus Aid, Relief, and Economic Security (CARES) Act, 85 Fed. Reg. 37331 (June 22, 2020)","title":"Video Visiting and Telephone Calls Under the Coronavirus Aid, Relief, and Economic Security (CARES) Act","dateIssued":"2020-06-22","startDate":"2020-06-22","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["OTHER","GATH"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-071","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-071"},{"id":"AGY-FED-HEALTH-OTHER-021","kind":"context","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Drug Enforcement Administration, Diversion Control Division (guidance document EO-DEA213)","instrument":"DEA-DC-043 (EO-DEA213), guidance: Administering certain controlled substances in the parking lot of a health care provider\u0027s DEA-registered location during the COVID-19 public health emergency","title":"Administering Certain CS in the parking lot of a healthcare provider\u0027s DEA-registered location during the COVID-19 public health emergency","dateIssued":"2020-07-28","startDate":"2020-07-28","endDate":"2021-09-30","quarters":["2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-021","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-021"},{"id":"AGY-FED-HEALTH-OTHER-022","kind":"context","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Drug Enforcement Administration, Diversion Control Division (guidance document EO-DEA192)","instrument":"DEA-DC-044 (EO-DEA192), guidance: Telemedicine and separate State registration","title":"Telemedicine: Will I need to hold a separate DEA registration in the state where my patients are located?","dateIssued":"2020-07-28","startDate":"2020-07-28","endDate":"","quarters":["2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-022","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-022"},{"id":"AGY-FED-HEALTH-OTHER-055","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration (Office of the Chief Scientist)","instrument":"Emergency Use Authorization: Surgical Masks (umbrella) (issued Aug. 5, 2020; reissued Mar. 6, 2023)","title":"Letter of Authorization, Surgical Masks (reissued Mar. 6, 2023)","dateIssued":"2023-03-06","startDate":"2020-08-05","endDate":"2021-09-30","quarters":["2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-055","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-055"},{"id":"AGY-FED-HEALTH-OTHER-084","kind":"order","level":"federal","jurisdiction":"United States (federal); Social Security Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Social Security Administration (Andrew Saul, Commissioner)","instrument":"Interim Final Rule, Waiver of Recovery of Certain Overpayment Debts Accruing During the COVID-19 Pandemic Period, 85 Fed. Reg. 52909 (Aug. 27, 2020)","title":"Waiver of Recovery of Certain Overpayment Debts Accruing During the COVID-19 Pandemic Period","dateIssued":"2020-08-27","startDate":"2020-08-27","endDate":"2020-09-30","quarters":["2020Q3","2020Q4"],"types":["OTHER","TELE"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-084","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-084"},{"id":"AGY-FED-HEALTH-OTHER-099","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Agriculture, Food and Nutrition Service","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Nutrition Service, USDA","instrument":"Notice, Agency Information Collection Activities: Supplemental Nutrition Assistance Program Emergency Allotments (COVID-19), 85 Fed. Reg. 52940 (Aug. 27, 2020)","title":"Agency Information Collection Activities: Supplemental Nutrition Assistance Program Emergency Allotments (COVID-19)","dateIssued":"2020-08-27","startDate":"2020-08-27","endDate":"2020-09-30","quarters":["2020Q3"],"types":["OTHER","EMER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-099","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-099"},{"id":"AGY-FED-HEALTH-OTHER-100","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Agriculture, Food and Nutrition Service","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Nutrition Service, USDA","instrument":"Notice, Agency Information Collection Activities: FNS Information Collection Needs due to COVID-19, 85 Fed. Reg. 52938 (Aug. 27, 2020)","title":"Agency Information Collection Activities: FNS Information Collection Needs due to COVID-19","dateIssued":"2020-08-27","startDate":"2020-08-27","endDate":"2022-06-30","quarters":["2020Q3"],"types":["SCH","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-100","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-100"},{"id":"AGY-FED-HEALTH-OTHER-078","kind":"order","level":"federal","jurisdiction":"United States (federal); Federal Bureau of Prisons","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Federal Bureau of Prisons","instrument":"Bureau to Resume Social Visitation: non-contact social visits to resume Oct. 3, 2020 under Phase Nine modifications (Sept. 30, 2020)","title":"Bureau to Resume Social Visitation - Non-contact social visits to resume October 3rd","dateIssued":"2020-09-30","startDate":"2020-10-03","endDate":"2021-09-30","quarters":["2020Q4","2021Q1","2021Q2","2021Q3"],"types":["GATH","CAP","MASK","QUAR"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-078","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-078"}],"facets":{"kind":[{"value":"order","label":"Order","count":40},{"value":"context","label":"Context (guidance or announcement)","count":6}],"level":[{"value":"federal","label":"Federal","count":46}],"state":[],"type":[{"value":"OTHER","label":"Other","count":29},{"value":"HC","label":"Health care orders","count":27},{"value":"SUPPLY","label":"Supply chain","count":9},{"value":"TELE","label":"Telework mandate","count":7},{"value":"SCH","label":"Schools and child care","count":6},{"value":"GATH","label":"Gathering cap","count":4},{"value":"EMP","label":"Workplace rules","count":3},{"value":"MASK","label":"Face-covering requirement","count":3},{"value":"VAX","label":"Vaccination or testing","count":3},{"value":"CLOSE","label":"Business closure","count":2},{"value":"QUAR","label":"Quarantine and isolation","count":2},{"value":"TRAV","label":"Travel and quarantine","count":2},{"value":"CAP","label":"Capacity limit","count":1},{"value":"CRT","label":"Courts and public offices","count":1},{"value":"EMER","label":"Emergency declaration","count":1}],"quarter":[{"value":"2021Q3","label":"2021 Q3","count":33},{"value":"2021Q1","label":"2021 Q1","count":26},{"value":"2021Q2","label":"2021 Q2","count":26},{"value":"2020Q4","label":"2020 Q4","count":25},{"value":"2020Q3","label":"2020 Q3","count":22},{"value":"2020Q2","label":"2020 Q2","count":18}],"grade":[{"value":"primary","label":"Primary source read","count":45},{"value":"secondary","label":"Confirmed from a secondary source","count":1}],"industry":[],"agency":[{"value":"FED-HEALTH-OTHER","label":"Other federal health agencies","count":46}]}}